GB Patent

GB2090605A — Polymer of diallyl ammonium monomers pharmaceutical compositions thereof

Assigned to Smith and Nephew PLC · Expires 1982-07-14 · 44y expired

What this patent protects

Polymers containing 55 to 90% of units of the formula (A) :wherein R<sup>1</sup> is a hydrogen atom or an alkyl group of 1 to 3 carbon atoms; and 10 to 45% of units of the formula (B) and (C):wherein R<sup>2</sup> is a hydrogen group of 5 to 19 carbon atom…

USPTO Abstract

Polymers containing 55 to 90% of units of the formula (A) :wherein R<sup>1</sup> is a hydrogen atom or an alkyl group of 1 to 3 carbon atoms; and 10 to 45% of units of the formula (B) and (C):wherein R<sup>2</sup> is a hydrogen group of 5 to 19 carbon atoms, for example n-C<sub>11</sub>H<sub>23</sub>, R<sup>3</sup> is a hydrogen atom or an alkyl group of 1 to 3 carbon atoms, R<sup>4</sup> is a hydrocarbon group of 5 to 19 carbon atoms, for example n-C<sub>11</sub>H<sub>23</sub> and X<sup>-</sup> is an anion and which contain at least 10% of units of formula (C) and are free from polymeric species having a molecular weight of less than 10,000 are described. The polymers possess antimicrobial activity against common pathogens. Isotonic aqueous solutions containing 0.002 to <sub>0</sub>.<sub>0</sub>25% of the polymer are suitable for the sterilisation of contact lenses for example by immersion of the lens in the solution overnight. Hydrophilic ointments containing from 0.002 to 0.25% of the polymer are suitable for the treatment of bacterial infection of lesions of the skin such as burns and ulcers.

Drugs covered by this patent

Patent Metadata

Patent number
GB2090605A
Jurisdiction
GB
Classification
Expires
1982-07-14
Drug substance claim
No
Drug product claim
No
Assignee
Smith and Nephew PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.